Tuberculosis, COVID-19, and the End Tuberculosis strategy in India.
作者信息
Behera Digambar
机构信息
Department of Pulmpnary Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
出版信息
Lung India. 2020 Nov-Dec;37(6):467-472. doi: 10.4103/lungindia.lungindia_544_20.
Abstract
摘要
相似文献
1
Tuberculosis, COVID-19, and the End Tuberculosis strategy in India.印度的结核病、新冠疫情与终结结核病战略
Lung India. 2020 Nov-Dec;37(6):467-472. doi: 10.4103/lungindia.lungindia_544_20.
2
Tuberculosis in the era of COVID-19 in India.印度新冠疫情时代的结核病
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1439-1443. doi: 10.1016/j.dsx.2020.07.034. Epub 2020 Jul 29.
3
Tuberculosis and COVID-19 in India- double trouble!印度的结核病与新冠疫情——双重麻烦！
Indian J Tuberc. 2020 Dec;67(4S):S175-S176. doi: 10.1016/j.ijtb.2020.07.014. Epub 2020 Jul 17.
4
COVID-19 and tuberculosis: A mathematical model based forecasting in Delhi, India.新型冠状病毒肺炎与结核病：基于数学模型对印度德里的预测
Indian J Tuberc. 2020 Apr;67(2):177-181. doi: 10.1016/j.ijtb.2020.05.006. Epub 2020 May 12.
5
The case of pulmonary tuberculosis with COVID-19 in an Indian male-a first of its type case ever reported from South Asia.一名印度男性同时感染肺结核和新冠病毒的病例——这是南亚地区首次报告的此类病例。
Pan Afr Med J. 2020 Aug 31;36:374. doi: 10.11604/pamj.2020.36.374.24260. eCollection 2020.
6
Impact of COVID-19 on tuberculosis services in India.2019冠状病毒病对印度结核病服务的影响。
Int J Tuberc Lung Dis. 2020 Jun 1;24(6):637-639. doi: 10.5588/ijtld.20.0212.
7
Tuberculosis control in India: Refocus on nutrition.印度的结核病控制：重新聚焦于营养。
Indian J Tuberc. 2019 Jan;66(1):26-29. doi: 10.1016/j.ijtb.2018.10.001. Epub 2018 Nov 2.
8
The End TB Strategy : India can blaze the trail.终结结核病战略：印度可以率先垂范。
Indian J Med Res. 2015 Mar;141(3):259-62. doi: 10.4103/0971-5916.156536.
9
Glycemic control monitoring in patients with tuberculosis and diabetes: a descriptive study from programmatic setting in Tamil Nadu, India.结核病合并糖尿病患者的血糖控制监测：来自印度泰米尔纳德邦项目环境的描述性研究。
F1000Res. 2019 Oct 7;8:1725. doi: 10.12688/f1000research.20781.2. eCollection 2019.
10
Training strategies practiced for TB elimination.为消除结核病而实施的培训策略。
Indian J Tuberc. 2020 Dec;67(4S):S79-S85. doi: 10.1016/j.ijtb.2020.11.007. Epub 2020 Nov 17.
引用本文的文献
1
Assessing the impact of COVID-19 management on the workload of human resources working in India's National Tuberculosis Elimination Program.评估新冠疫情管理对印度国家消除结核病计划中人力资源工作量的影响。
BMC Health Serv Res. 2024 Aug 7;24(1):907. doi: 10.1186/s12913-024-11131-8.
2
Impact of COVID-19 Pandemic on Tuberculosis Preventive Services and Their Post-Pandemic Recovery Strategies: A Rapid Review of Literature.COVID-19 大流行对结核病预防服务的影响及其大流行后的恢复策略：文献快速综述。
J Korean Med Sci. 2023 Feb 6;38(5):e43. doi: 10.3346/jkms.2023.38.e43.
3
Pulmonary cavitation in follow-up COVID 2019 cases: An etiological perspective.2019冠状病毒病后续病例中的肺空洞形成：病因学视角
Med J Armed Forces India. 2022 Aug 19;80(Suppl 1):S29-37. doi: 10.1016/j.mjafi.2022.06.015.
4
Aftermath of COVID-19 and Critical Care in India.印度的新冠疫情后果与重症护理
Indian J Crit Care Med. 2021 Oct;25(10):1173-1175. doi: 10.5005/jp-journals-10071-23987.
5
COVID-19 & the National Tuberculosis Elimination Programme of India.新冠疫情与印度国家结核病消除计划
Indian J Med Res. 2021 May;153(5&6):533-536. doi: 10.4103/ijmr.IJMR_2763_20.
6
COVID-19 and pulmonary tuberculosis - A diagnostic dilemma.新型冠状病毒肺炎与肺结核——诊断难题
Radiol Case Rep. 2021 Nov;16(11):3255-3259. doi: 10.1016/j.radcr.2021.07.079. Epub 2021 Aug 2.
7
The impact of COVID-19 on TB: a review of the data.COVID-19 对结核病的影响：数据回顾。
Int J Tuberc Lung Dis. 2021 Jun 1;25(6):436-446. doi: 10.5588/ijtld.21.0148.
本文引用的文献
1
Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.结核病和 COVID-19：从过去的病毒爆发中吸取教训和可能的未来结果。
Can Respir J. 2020 Sep 5;2020:1401053. doi: 10.1155/2020/1401053. eCollection 2020.
2
Lessons learnt during the first 100 days of COVID-19 pandemic in India.印度新冠疫情头100天期间汲取的经验教训。
Indian J Med Res. 2020 May;151(5):387-391. doi: 10.4103/ijmr.IJMR_1925_20.
3
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).传染病和大流行病病毒感染：对结核病和肺部的影响：世界传染病和免疫障碍协会（WAidid）、全球结核病网络（GTN）以及欧洲临床微生物学和传染病学会分枝杆菌感染研究组（ESGMYC）成员的共识。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.01727-2020. Print 2020 Oct.
4
Impact of COVID-19 on tuberculosis services in India.2019冠状病毒病对印度结核病服务的影响。
Int J Tuberc Lung Dis. 2020 Jun 1;24(6):637-639. doi: 10.5588/ijtld.20.0212.
5
Helping Africa to breathe when COVID-19 strikes.在新冠疫情来袭时助力非洲应对危机。
Int J Tuberc Lung Dis. 2020 Jun 1;24(6):636-637. doi: 10.5588/ijtld.20.0208.
6
Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital.意大利某参考医院中 COVID-19 与活动性肺结核合并感染的临床特征。
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01708-2020. Print 2020 Jul.
7
A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.全面更新的关于 SARS-CoV-2 和 COVID-19 的综述。
J Clin Pharmacol. 2020 Aug;60(8):954-975. doi: 10.1002/jcph.1673. Epub 2020 Jun 24.
8
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.活动性肺结核、后遗症与 COVID-19 合并感染：49 例首批队列。
Eur Respir J. 2020 Jul 9;56(1). doi: 10.1183/13993003.01398-2020. Print 2020 Jul.
9
Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes.预测 COVID-19 大流行对结核病患者和结核病控制规划的影响。
Ann Clin Microbiol Antimicrob. 2020 May 23;19(1):21. doi: 10.1186/s12941-020-00363-1.
10
Postmortem Examination of Patients With COVID-19.COVID-19 患者的尸检。
JAMA. 2020 Jun 23;323(24):2518-2520. doi: 10.1001/jama.2020.8907.
Zotero 插件